TARS - Tarsus Pharmaceuticals GAAP EPS of -$1.28 beats by $0.11 revenue of $1.9M beats by $1.54M
2023-11-09 16:34:52 ET
More on Tarsus Pharmaceuticals
- Xdemvy: Tarsus' Leading Asset In A Multi-Billion Market Landscape
- Tarsus Pharmaceuticals, Inc. - Barking Up The Wrong Tree
- Tarsus Pharmaceuticals: Worthy Of A Small Bet
- Tarsus Pharmaceuticals' President & CEO disposes 8,000 shares
- Seeking Alpha’s Quant Rating on Tarsus Pharmaceuticals
For further details see:
Tarsus Pharmaceuticals GAAP EPS of -$1.28 beats by $0.11, revenue of $1.9M beats by $1.54M